Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Nicholson

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Thorax|October 1, 1991
Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory diseaseM J Wiselka, K G Nicholson, J Kent, et al.
Developments in Biological Standardization|January 1, 1986
Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animalsJ M Wood, J Mumford, G C Schild, et al.
Journal of Clinical Microbiology|April 1, 1992
Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprintingJ Schmid, F C Odds, M J Wiselka, et al.
Journal of Medical Virology|January 1, 1982
Neonatal rotavirus infection: role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protectionB M Totterdell, K G Nicholson, J MacLeod, et al.
Epidemiology and Infection|February 1, 1997
Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemicA H Ahmed, K G Nicholson, J S Nguyen-van Tam, et al.
Lancet (London, England)|September 3, 1983
Live influenza vaccinesK G Nicholson, D A Tyrrell, C H Howells, et al.
Lancet (London, England)|June 26, 1976
Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small dosesG S Turner, F Y Aoki, K G Nicholson, et al.
Epidemiology and Infection|December 1, 1990
Acute upper respiratory tract viral illness and influenza immunization in homes for the elderlyK G Nicholson, D J Baker, A Farquhar, et al.
Lancet (London, England)|June 27, 2001
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaK G Nicholson, A E Colegate, A Podda, et al.
Medical Microbiology and Immunology|November 30, 2002
Experience with the clinical development of influenza vaccines for potential pandemicsJ M Wood, K G Nicholson, I Stephenson, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Thorax|October 1, 1991
Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory diseaseM J Wiselka, K G Nicholson, J Kent, et al.
Developments in Biological Standardization|January 1, 1986
Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animalsJ M Wood, J Mumford, G C Schild, et al.
Journal of Clinical Microbiology|April 1, 1992
Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprintingJ Schmid, F C Odds, M J Wiselka, et al.
Journal of Medical Virology|January 1, 1982
Neonatal rotavirus infection: role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protectionB M Totterdell, K G Nicholson, J MacLeod, et al.
Epidemiology and Infection|February 1, 1997
Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemicA H Ahmed, K G Nicholson, J S Nguyen-van Tam, et al.
Lancet (London, England)|September 3, 1983
Live influenza vaccinesK G Nicholson, D A Tyrrell, C H Howells, et al.
Lancet (London, England)|June 26, 1976
Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small dosesG S Turner, F Y Aoki, K G Nicholson, et al.
Epidemiology and Infection|December 1, 1990
Acute upper respiratory tract viral illness and influenza immunization in homes for the elderlyK G Nicholson, D J Baker, A Farquhar, et al.
Lancet (London, England)|June 27, 2001
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaK G Nicholson, A E Colegate, A Podda, et al.
Medical Microbiology and Immunology|November 30, 2002
Experience with the clinical development of influenza vaccines for potential pandemicsJ M Wood, K G Nicholson, I Stephenson, et al.
Pageof 11